Merck KGaA: This time we’ve got our R&D act together (seriously)
Merck KGaA has one of the worst R&D track records of any biopharma company of its size. Its life sciences group has gone well over …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
